Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86/JN.1 lineage

3 Oct 2024

Abstract excerpt

The SARS-CoV-2 BA.2.86 lineage, and its sublineage JN.1 in particular, achieved widespread transmission in the US during winter 2023-24. However, this surge in infections was not accompanied by COVID-19 hospitalizations and mortality commensurate with prior waves. To understand shifts in COVID-19 epidemiology associated with JN.1 emergence, we compared characteristics and clinical outcomes of time-matched cases...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to COVID-19 epidemiological studies
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39362845
DOI: 10.1038/s41467-024-52668-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86/JN.1 lineagePMID 39362845Read ↗

Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86/JN.1 lineageSemantic proximity Read ↗

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasionSemantic proximity Read ↗

Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity — IVY Network, 26 Hospitals, October 18, 2023–March 9, 2024Semantic proximity Read ↗

Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcomeSemantic proximity Read ↗

Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcomeSemantic proximity Read ↗

Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages — United States, May 2023–September 2024Semantic proximity Read ↗

Increased vaccine sensitivity of an emerging SARS-CoV-2 variantSemantic proximity Read ↗

Increased vaccine sensitivity of an emerging SARS-CoV-2 variantSemantic proximity Read ↗

Integrated Genomic and Virological SARS-CoV-2 Surveillance in Germany 2022/23: Monitoring Viral Evolution and Epidemiological CharacteristicsSemantic proximity Read ↗

XBB.1.5 mRNA COVID-19 Vaccination and Inpatient or Emergency Department Visits Among Adults Infected with SARS-CoV-2 JN.1 and XBB-Lineage VariantsSemantic proximity Read ↗

Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasionSemantic proximity Read ↗

Distinct Patterns of SARS-CoV-2 BA.2.87.1 and JN.1 Variants in Immune Evasion, Antigenicity and Cell-Cell FusionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.